Description: Many insurance companies have started Diversity, Equity, and Inclusion (DEI) initiatives over the past few years to better engage with their employees and communities in new ways. Explore another important audience of DEI programs: the customers who purchase insurance products. Review research on the unique needs of specific groups that may have been underserved by insurance companies in the past. You will also touch on ways to make the insurance buying process more accessible to everyone.

Description: Come discuss inforce management techniques that go beyond the traditional methods of adjusting non-guaranteed elements within contractual limits. Methods such as retention, cross-selling/up-selling, wellness, exchange programs and other customer behavior initiatives will be presented with relevant considerations.

Description: 2021 Life Meeting - Session 8A: Use of Electronic Health Records in the Assessment of Life and Health Risks 9.1.21 Recording

Description: 2021 Life Meeting - Session 7D: Emerging Trends in Lapse and Mortality for Life Products 9.1.21 Recording

Description: The current economic environment has forced insurers to make changes in an effort to continue to write profitable business. This session will discuss profitability measures, pricing methodologies, assumption setting as well as explore trends of life insurance marketplaces and impacts of regulations.

Description: 2021 Life Meeting - Session 4E: LDTI Earnings Analysis for Life Products 8.31.21 Recording

Description: With long duration targeted improvements in the U.S., and IFRS 17 in other countries, the insurance industry is currently undergoing the adoption of two of the most significant accounting changes in recent history. While the scale of these specific events are infrequent, change is the norm in the world of insurance and life of an actuary. We live in a dynamic environment that will continue to bring challenges in how companies make decisions in order maximize their value and return on capital. Capital management requires an ability for insurance companies to take corporate actions and understand the impact this will have on both the current and future available capital. Being able to make optimal decisions when the goal posts are subject to frequent and material shifts in accounting regulation is a difficult process. It requires holistic consideration of all tools available to manage capital and how KPIs can shift in their measurement under new regimes. By attending the session, you will: Discuss the challenges that companies have in managing capital in an ever evolving environment, what steps they have taken in managing the current scope of accounting change, and how they can be prepared for adjustments in the future.

Description: The use of longevity swaps are an area of growing interest in North America for insurers and pension schemes to manage their exposure to longevity risk. This growth is anticipated to continue as a consequence of the increased experience in the market and this maturity will encourage an improved affordability and ability for insurers to be flexible in this space. In Europe and Asia, longevity swaps are a much more established tool for risk transfer and optimizing asset-liability matching. From these markets, we can learn how to establish an effective framework in order to price, implement, and monitor performance of longevity swaps. By attending the session, you will be informed on the typical structure and modeling/valuation approach for longevity swaps including: - Understand longevity swap concepts, their benefits and common use. - Establish a basis for assessment such asmeasurement metrics, risk factors, and benchmarking principles. - Comprehend ongoing management such as basis risk, trigger points/pull-out clauses, potential operational issues, and asset transfer mechanisms. - Understand considerations and approach for valuing under US STAT and US GAAP.

Description: In summer 2021, the SOA Research Institute’s Mortality and Longevity Strategic Research Program sponsored a webcast examining individual life and group life emerging mortality in a COVID-19 world. Since then, Delta and Omicron coronavirus variants have fueled waves of the virus in the U.S., boosting the total number of COVID-19 deaths since the beginning of the pandemic to near the 1 million mark. Hear an update and insights into how the life insured population is faring during COVID-19 by discussing the findings from two recent SOA Research Institute initiatives. LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries (SOA) and TAI have collaborated to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience. Additionally, the SOA Research Institute has surveyed insurers to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic, comparing them to pre-pandemic mortality levels. The Group Term Life industry mortality results will be presented with monthly data through March 2022.

Description: Take part in an interactive session where experts from a variety of backgrounds and disciplines debate hot topics in underwriting and the impact they may have on key business outcomes such as mortality. Cast the deciding vote on each question. The debate will cover topics such as: - Leading performance indicators - are we measuring the right things? - Is the ground shifting beneath us? Less obvious, tertiary factors that could influence mortality - How much is too much? How far can we push the envelope on qualification with limited evidence? By attending the session, you will: - Identify key questions to consider relative to the continuing evolution of underwriting. - Recognize pros and cons to solutions currently in production or under consideration. - Understand potential business impacts of forthcoming underwriting changes and levers that could increase or reduce their magnitude.